A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study
Titel:
A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study
Auteur:
Gold, Julian Marta, Monica Meier, Ute C. Christensen, Tove Miller, David Altmann, Daniel Holden, David Bianchi, Lucia Adiutori, Rocco MacManus, David Yousry, Tarek Schmierer, Klaus Turner, Benjamin Giovannoni, Gavin